Tag: Pharmaceuticals

Displaying 1 - 20 of 87 results.

Pages

The Federal Trade Commission has sent a report to Congress about the effects that so-called rebate walls have on competition in markets for pharmaceutical and biopharmaceutical drugs.
Staff from the Federal Trade Commission, Canada’s Competition Bureau, the European Commission Directorate General for Competition, the U.K.’s Competition and Markets Authority, the U.S.
The Federal Trade Commission is sending 51,875 payments totaling more than $59 million to consumers who were victims of an allegedly deceptive scheme by Reckitt Benckiser Group and
Note: The FTC will host a conference call TODAY for media at 11:30 ET with Acting Chairwoman Rebecca Kelly Slaughter. The call-in number is 844-291-6360 and the access code is 4928954. Call-in lines, which are for media only, will open 15 minutes prior to the start of the call.
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that the combination of the Upjohn division of pharmaceutical company Pfizer and Mylan N.V. would violate federal antitrust law.
According to a new FTC staff report, the total number of final Hatch-Waxman patent settlements entered by pharmaceutical companies in FY 2017 was close to the record high in FY 2016. Despite the high number of settlements, those that include the types of reverse payments that are likely to be...
Pharmaceutical companies Pfizer Inc. and Mylan N.V. have agreed to divest assets and abide by other conditions to settle Federal Trade Commission charges that the proposed combination of Upjohn Inc. and Mylan N.V. will harm current or future competition in ten generic drug markets. Under the...
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that AbbVie’s $63 billion acquisition of Allergan would violate federal antitrust law.
In July 2020, the FTC required global suppliers of animal products, Elanco Animal Health, Inc. and Bayer Animal Health GmbH, to divest three animal health products to settle charges that Elanco’s proposed $7.6 billion acquisition of Bayer would likely be anticompetitive in those...

Pages